BamSEC and AlphaSense Join Forces
Learn More

SELLAS Life Sciences Group Inc. – Material Contracts

NASDAQ: SLS    
Share price (7/6/26): $13.94    
Market cap (7/6/26): $2.593 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 8 pages June 24, 2026 Dragan Cicic, M.D. C/O SELLAS Life Sciences Group, Inc. 7 Times Square, Suite 2503 New York, Ny 10036 Re: Amended and Restated Severance and Change of Control Letter Agreement 1. Definitions
12/34/56
EX-10.2
from 8-K 8 pages June 24, 2026 John Burns C/O SELLAS Life Sciences Group, Inc. 7 Times Square, Suite 2503 New York, Ny 10036 Re: Amended and Restated Severance and Change of Control Letter Agreement 1. Definitions
12/34/56
EX-10.1
from 8-K 3 pages June 24, 2026 Angelos M. Stergiou, M.D., SC.D. H.C. C/O SELLAS Life Sciences Group, Inc. 7 Times Square, Suite 2503 New York, Ny 10036 Re: Amendment to Employment Agreement 1. Severance. the Agreement Is Hereby Amended by Replacing Section 4(j) of the Agreement With the Following
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.1
from 8-K 2 pages October 1, 2025 SELLAS Life Sciences Group, Inc. 7 Times Square, 25th Floor, New York Ny 10036 Re: Time Square Tower, 7 Time Square, New York, Ny (The “Building”) Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 13 pages Material contract
12/34/56
EX-10.1
from 10-Q 8 pages SELLAS Life Sciences Group, Inc. Amended and Restated Employee Stock Purchase Plan Amended and Restated on June 17, 2025
12/34/56
EX-10.13
from 10-K 2 pages February __, 2025 Personal and Confidential Re: Amendment to Change in Control Severance Agreement
12/34/56
EX-10.12
from 10-K 2 pages February __, 2025 Personal and Confidential Re: Amendment to Change in Control Severance Agreement
12/34/56
EX-10.11
from 10-K 7 pages January 22, 2024 1. Severance
12/34/56
EX-10.9
from 10-K 3 pages Employment: You Will Be Employed on a Full-Time Basis as Senior Vice President, Clinical Research & Development, in Our New York Office, Commencing on February 3, 2020. You Will Report to the Company’s Chief Executive Officer (The “CEO”) and Have the Duties and Responsibilities That Are Consistent With Your Position and Such Other Duties as May From Time to Time Be Assigned to You by the Company
12/34/56
EX-10.1
from 8-K 29 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages October 2, 2024 SELLAS Life Sciences Group, Inc. 7 Times Square, 25th Floor, New York Ny 10036 Re: Time Square Tower, 7 Time Square, New York, Ny (The “Building”) Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 29 pages Securities Purchase Agreement
12/34/56
EX-10.51
from 10-K 15 pages Separation Agreement and General Release
12/34/56
EX-10.50
from 10-K 15 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because SELLAS Life Sciences Group, Inc. Has Determined the Information (I) Is Not Material and (II) the Company Customarily Treats That Information as Private. Date Provided to Employee: March 8, 2024 Confidential Separation Agreement and General Release
12/34/56
EX-10.49
from 10-K 3 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because SELLAS Life Sciences Group, Inc. Has Determined the Information (I) Is Not Material and (II) the Company Customarily Treats That Information as Private. February 25, 2022
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 6 pages Second Amendment to Sublease
12/34/56